In the present study, upregulation of heme oxygenase 1 (HO-1) was shown for the first time in primary BRAFV600E melanoma cells adapted to physiological oxygen tension and hypoxia to limit the efficacy of Vemurafenib/PLX4032. The gene discussed is HMOX1; the disease is melanoma.